Anti-angiogenic therapy for lung cancer
Editorial Group: Cochrane Lung Cancer Group
Published Online: 7 OCT 2009
Assessed as up-to-date: 3 JUL 2009
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Pavlakis N, Marx G, White S, Lee CW, Khasraw M. Anti-angiogenic therapy for lung cancer (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008047. DOI: 10.1002/14651858.CD008047.
- Publication Status: Edited (no change to conclusions)
- Published Online: 7 OCT 2009
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the benefits and harms of angiogenesis inhibitors in the treatment of lung cancer when given alone, following or in combination with chemotherapy or chemo-radiotherapy (in the case of locally advanced non-metastatic NSCLC or limited stage SCLC).